Ovarian Cancer: Applications of Chickens to Humans
- PMID: 35167319
- DOI: 10.1146/annurev-animal-021419-084001
Ovarian Cancer: Applications of Chickens to Humans
Abstract
The lack of preclinical models of spontaneous ovarian cancer (OVCA), a fatal gynecological malignancy, is a significant barrier to generating information on early changes indicative of OVCA. In contrast to rodents, laying hens develop OVCA spontaneously, with remarkable similarities to OVCA in women regarding tumor histology, OVCA dissemination, immune responses, and risk factors. These important features of OVCA will be useful to develop an early detection test for OVCA, which would significantly reduce mortality rates; preventive strategies; immunotherapeutics; prevention of resistance to chemotherapeutics; and exploration of gene therapies. A transvaginal ultrasound (TVUS) imaging method for imaging of hen ovarian tumors has been developed. Hens can be monitored prospectively by using serum markers, together with TVUS imaging, to detect early-stage OVCA, provided that a panel of serum markers can be established and imaging agents developed. Recent sequencing of the chicken genome will further facilitate the hen model to explore gene therapies against OVCA.
Keywords: animal model; chicken; early detection; ovarian cancer; prevention; risk factors.
Similar articles
-
Enhancement of Ovarian Tumor Detection by DR6-Targeted Ultrasound Imaging Agents in Laying Hen Model of Spontaneous Ovarian Cancer.Int J Gynecol Cancer. 2016 Oct;26(8):1375-85. doi: 10.1097/IGC.0000000000000784. Int J Gynecol Cancer. 2016. PMID: 27465898
-
Interleukin 16- (IL-16-) Targeted Ultrasound Imaging Agent Improves Detection of Ovarian Tumors in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.Biomed Res Int. 2015;2015:567459. doi: 10.1155/2015/567459. Epub 2015 Jun 16. Biomed Res Int. 2015. PMID: 26161406 Free PMC article.
-
VEGFR2-Targeted Ultrasound Imaging Agent Enhances the Detection of Ovarian Tumors at Early Stage in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.Ultrason Imaging. 2015 Jul;37(3):224-37. doi: 10.1177/0161734614553603. Epub 2014 Oct 6. Ultrason Imaging. 2015. PMID: 25294846
-
Epithelial ovarian cancer experimental models.Oncogene. 2014 Jul 10;33(28):3619-33. doi: 10.1038/onc.2013.321. Epub 2013 Aug 12. Oncogene. 2014. PMID: 23934194 Free PMC article. Review.
-
The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine.Int J Mol Sci. 2022 Sep 1;23(17):9981. doi: 10.3390/ijms23179981. Int J Mol Sci. 2022. PMID: 36077371 Free PMC article. Review.
Cited by
-
Single-cell transcriptome analysis revealed heterogeneity in glycolysis and identified IGF2 as a therapeutic target for ovarian cancer subtypes.BMC Cancer. 2024 Jul 31;24(1):926. doi: 10.1186/s12885-024-12688-7. BMC Cancer. 2024. PMID: 39085784 Free PMC article.
-
Nutraceutical-Based Nanoformulations for Breast and Ovarian Cancer Treatment.Int J Mol Sci. 2022 Oct 10;23(19):12032. doi: 10.3390/ijms231912032. Int J Mol Sci. 2022. PMID: 36233349 Free PMC article. Review.
-
FoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated m6A modification of SMC4.Cancer Sci. 2024 Apr;115(4):1224-1240. doi: 10.1111/cas.16120. Epub 2024 Feb 25. Cancer Sci. 2024. PMID: 38403332 Free PMC article.
-
Single-Cell and Spatial Transcriptomics Explore Purine Metabolism-Related Prognostic Risk Model and Tumor Immune Microenvironment Modulation in Ovarian Cancer.Hum Mutat. 2025 May 9;2025:5530325. doi: 10.1155/humu/5530325. eCollection 2025. Hum Mutat. 2025. PMID: 40386292 Free PMC article.
-
Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma.Cancers (Basel). 2023 Jan 21;15(3):661. doi: 10.3390/cancers15030661. Cancers (Basel). 2023. PMID: 36765618 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical